Return On Assets of Celldex Therapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Celldex Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Celldex Therapeutics, Inc. Return On Assets for the quarter ending 31 Dec 2025 was -39%, a 105% decline year-over-year.
  • Celldex Therapeutics, Inc. annual Return On Assets for 2025 was -39%, a 105% decline from 2024.
  • Celldex Therapeutics, Inc. annual Return On Assets for 2024 was -19%, a 54% increase from 2023.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Celldex Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -39% -20% -105% 01 Oct 2025 31 Dec 2025
Q3 2025 -31% 01 Jul 2025 30 Sep 2025
Q2 2025 -26% 01 Apr 2025 30 Jun 2025
Q1 2025 -22% 01 Jan 2025 31 Mar 2025
Q4 2024 -19% 01 Oct 2024 31 Dec 2024

Celldex Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 -39% -20% -105% 01 Jan 2025 31 Dec 2025
2024 -19% +22% +54% 01 Jan 2024 31 Dec 2024
2023 -41% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.